Request an Appointment:
Online or Call 1-888-824-0200

Cardiac Amyloidosis Research

Clinicians and researchers across the University of Chicago Medicine are investigating amyloidosis to understand its causes and discover new methods for treating or preventing the disease. Currently, we are conducting a long-term study of patients with TTR amyloidosis to better comprehend and characterize the natural history of the disease. Our goal is to develop new treatment guidelines and recommendations, as well as educate clinicians about the management of the disease. Additional research being conducted by the team includes:

  • Evaluating the use of novel drug therapies to treat amyloidosis
  • Gaining a better understanding of the underlying hemodynamics of cardiac amyloidosis
  • Developing novel ways to treat patients with advanced cardiac amyloidosis that are not candidates for transplantation

Our leading-edge research enables us to bring the forefront of amyloidosis care to our patient's bedside through clinical trials. With these trials, we offer patients access to the newest treatments not yet universally available. «Learn more about the cardiac clinical trials offered at the University of Chicago Medicine.

More Information